References
- ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
- ZhouYZhangXGuCXiaJDiabetes mellitus is associated with breast cancer: systematic review, meta-analysis, and in silico reproductionPanminerva Med201557310110825971328
- HuxleyRAnsary-MoghaddamABerrington de GonzalezABarziFWoodwardMType-II diabetes and pancreatic cancer: a meta-analysis of 36 studiesBr J Cancer200592112076208315886696
- GurayaSYAssociation of type 2 diabetes mellitus and the risk of colorectal cancer: a meta-analysis and systematic reviewWorld J Gastroenterol201521196026603126019469
- FangHYaoBYanYDiabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studiesDiabetes Technol Ther2013151191492224180357
- El-SeragHBHampelHJavadiFThe association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidenceClin Gastroenterol Hepatol20064336938016527702
- JonassonJMLjungRTalbackMHaglundBGudbjornsdottirSSteineckGInsulin glargine use and short-term incidence of malignancies-a population-based follow-up study in SwedenDiabetologia20095291745175419588120
- AdamiHOMcLaughlinJEkbomACancer risk in patients with diabetes mellitusCancer Causes Control1991253073141932543
- ShihSRChiuWYChangTCTsengCHDiabetes and thyroid cancer risk: literature reviewExp Diabetes Res2012201257828522778714
- Bjerre KnudsenLMadsenLWAndersenSGlucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferationEndocrinology201015141473148620203154
- LovshinJADruckerDJIncretin-based therapies for type 2 diabetes mellitusNat Rev Endocrinol20095526226919444259
- SheltonJGSteelmanLSWhiteERMcCubreyJASynergy between PI3K/Akt and Raf/MEK/ERK pathways in IGF-1R mediated cell cycle progression and prevention of apoptosis in hematopoietic cellsCell Cycle20043337237914726697
- FengCGaoYWangCAberrant overexpression of pyruvate kinase M2 is associated with aggressive tumor features and the BRAF mutation in papillary thyroid cancerJ Clin Endocrinol Metab2013989E1524E153323846818
- KarlstadOStarup LindeJVestergaardPUse of insulin and insulin analogs and risk of cancer; systematic review and meta-analysis of observational studiesCurr Drug Saf20138533334824215311
- HsiehMCLeeTCChengSMTuSTYenMHTsengCHThe influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the TaiwaneseExp Diabetes Res2012201241378222719752
- CarstensenBWitteDRFriisSCancer occurrence in Danish diabetic patients: duration and insulin effectsDiabetologia201155494895822120574
- HabelLADanforthKNQuesenberryCPCohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetesDiabetes Care201336123953396024170756
- DrejerKThe bioactivity of insulin analogs from in vitro receptor binding to in vivo glucose uptakeDiabetes Metab Rev1992832592851338040
- WeinsteinDSimonMYehezkelELaronZWernerHInsulin analogs display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cellsDiabetes Metab Res Rev2009251414919145584
- ShuklaAGrisouardJEhemannVHermaniAEnzmannHMayerDAnalysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell linesEndocr Relat Cancer200916242944119153208
- SciaccaLLe MoliRVigneriRInsulin analogs and cancerFront Endocrinol (Lausanne)201232122649410
- LiuYJQiangWShiJLvSQJiMJShiBYExpression and significance of IGF-1 and IGF-1R in thyroid nodulesEndocrine201344115816423288662
- SchmidtJAAllenNEAlmquistMInsulin-like growth factor-I and risk of differentiated thyroid carcinoma in the European prospective investigation into cancer and nutritionCancer Epidemiol Biomarkers Prev201423697698524646451
- RouseRXuLStewartSZhangJHigh fat diet and GLP-1 drugs induce pancreatic injury in miceToxicol Appl Pharmacol2014276210411424534256
- ElashoffMMatveyenkoAVGierBElashoffRButlerPCPancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapiesGastroenterology2011141115015621334333
- ZhaoHWangLWeiRActivation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathwayDiabetes Obes Metab201416985086024641303
- GierBButlerPCLaiCKKirakossianDDeNicolaMMYehMWGlucagon like peptide-1 receptor expression in the human thyroid glandJ Clin Endocrinol Metab201297112113122031513
- FangDHuangZGuanHThe Akt/FoxO1/p27 pathway mediates the proliferative action of liraglutide in beta cellsMol Med Rep20125123323821964769
- WeiQSunYQZhangJExendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic beta-cell linePeptides2012371182422776329
- ChallaTDBeatonNArnoldMRudofskyGLanghansWWolfrumCRegulation of adipocyte formation by GLP-1/GLP-1R signalingJ Biol Chem201228796421643022207759
- ChangWWLinRJYuJThe expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitorsBreast Cancer Res2013153R3923663564
- HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
- LeeJSeolMYJeongSA metabolic phenotype based on mitochondrial ribosomal protein expression as a predictor of lymph node metastasis in papillary thyroid carcinomaMedicine (Baltimore)2015942e38025590838